Lung Cancer in a U.S. Population with Low to Moderate Arsenic ExposureJulia E. Heck, Eric J. Duell, Angeline S. Andrew et al.|Environmental Health Perspectives|2009Cited by 160
A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapyJohn A. Glaspy, Alan Colowick, J. Jadeja et al.|British Journal of Cancer|2001Cited by 81
A phase II multicenter trial comparing two schedules of lapatinib (LAP) as first or second line monotherapy in subjects with advanced or metastatic non-small cell lung cancer (NSCLC) with either bronchioloalveolar carcinoma (BAC) or no smoking historyMichael Smylie, Helen J. Ross, G. R. Blumenschein et al.|Journal of Clinical Oncology|2007Cited by 32
A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancerH. Chen, Heather A. Wakelee, Julie R. Brahmer et al.|British Journal of Cancer|2013Cited by 26